Roche, obesity pill trial
Roche Not Alarmed by Obesity Drug’s Side Effects, R&D Head Says
Roche Holding AG said it isn’t concerned about side effects in a small study of a weight-loss shot, after details about the trial sent shares tumbling on Monday.
Roche data shows stomach-churning side effects of weight-loss drugs
The novel drugs work by mimicking the gut hormone GLP-1, which lowers blood sugar and limits the appetite. Treatments such as Eli Lilly’s Mounjaro also add another gut hormone, GIP, that appears to enhance weight loss. In addition, companies are experimenting with other gut and pancreatic hormones.
Roche shares knocked by concern over side effects in obesity pill trial
FRANKFURT (Reuters) -Shares in Roche dropped to a two-month low on Thursday after an experimental weight-loss pill that carries high market hopes was linked to an elevated rate of temporary side effects in its initial test phase on humans.
Roche Falls as Side Effects Data for Obesity Drug Raises Concern
Shares of Roche Holding AG fell after a poster highlighted side effects in an early-stage study of the Swiss pharmaceutical company’s experimental obesity medicine.
Roche Shares Slump on Oral Weight-Loss Drug Candidate Side Effects
Roche’s stock fell after new data from an early-stage clinical trial of its closely watched oral weight-loss drug candidate prompted analysts to question the company’s potential to quickly enter a booming obesity market.
Roche shares drop on side effects result in early-stage obesity pill trial
Shares in Roche fell on Thursday after an early-stage obesity pill candidate that carries high market hopes was linked to a high rate of temporary side effects in its initial test phase on humans. Roche shares were down 4% at the open at 0700 GMT after the company presented late on Wednesday details on the trial.
Roche Shares Drop on Concern About Obesity Pill Side Effects
Roche Holding AG said side effects in a highly anticipated study of its experimental obesity pill were milder when it eased patients into higher doses more slowly, seeking to reassure investors that it can compete in the next generation of weight loss drugs.
Roche's Manu Chakravarthy talks weight loss drug trial results
Manu Chakravarthy, Roche, joins 'Fast Money' to talk its weight loss drug trial results. Snap poll after debate reveals state of presidential race between Trump and Harris Save Money On Steak With This Easy Costco Shopping Tip If you always use these 6 phrases,
Roche shares slip on obesity drug trial side effects
Shares of Roche (SIX:RO) fell on Thursday following reports from an early-stage trial of an obesity medication, which showed a high rate of temporary side effects. At 4:44 am (0844 GMT), Roche was trading 4% lower at
Roche Obesity Pill Study: What Are the Side Effects?
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world
Berenberg Bank Sticks to Its Hold Rating for Roche Holding AG (RHHVF)
In a report released today, Luisa Hector from Berenberg Bank maintained a Hold rating on Roche Holding AG (RHHVF – Research Report), with ...
Yahoo Finance20d
Roche Holding AG (VTX:ROG) most popular amongst retail investors who own 55% of the shares, institutions hold 37%
Significant control over Roche Holding by retail investors implies ... Holding is held by Institutions Every investor in Roche Holding AG (VTX:ROG) should be aware of the most powerful ...
Roche's Antiviral Drug Reduces Transmission Of Influenza Viruses, Late-Stage Study Shows
Roche's phase 3 CENTERSTONE study shows Xofluza (baloxavir marboxil) significantly reduces influenza transmission in ...
Roche Holding AG: A Cautious Hold Amidst Competition and Pipeline Uncertainties
Stifel Nicolaus analyst Eric Le Berrigaud has maintained their neutral stance on RHHVF stock, giving a Hold rating today. Eric Le ...
Zacks.com on MSN5d
RHHBY or ABBV: Which Is the Better Value Stock Right Now?
But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out.Everyone has their own methods for finding great value opportunities, but our model ...
Yahoo Finance2d
Roche Holding AG (RHO6.SG)
SOUTH SAN FRANCISCO, Calif., September 19, 2024--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today positive topline results of the Phase III CENTERSTONE study of ...
Wall Street Journal2d
Roche Holding AG
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Respiree teams up with Roche Diagnostics in APAC to introduce a new simplified way of hospital patient monitoring
With this collaboration, Respiree's patient monitoring solution will be made available for healthcare professionals in APAC ...